CD19 and neoplasm: In a Raji lymphoma model using NSG immunodeficient mice, T cells carrying the parental anti-CD19-CAR-28z vector significantly prolonged the survival of tumor-bearing mice when compared with mice receiving PBS or mock-infected T cells (Fig. 8c).